BIOMAT Database Logo BIOMAT Database Logo

Infections in adult liver transplant patients under FK 506 immunosuppression. 1991

M Alessiani, and S Kusne, and M Martin, and A Jain, and K Abu-Elmagd, and J Moser, and S Todo, and J Fung, and T Starzl
Department of Surgery, University of Pittsburgh, Pennsylvania.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D009181 Mycoses Diseases caused by FUNGI. Fungus Diseases,Fungal Diseases,Fungal Infections,Fungus Infections,Disease, Fungal,Disease, Fungus,Diseases, Fungal,Diseases, Fungus,Fungal Disease,Fungal Infection,Fungus Disease,Fungus Infection,Infection, Fungal,Infection, Fungus,Infections, Fungal,Infections, Fungus
D009894 Opportunistic Infections An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression. Infection, Opportunistic,Infections, Opportunistic,Opportunistic Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D014777 Virus Diseases A general term for diseases caused by viruses. Viral Diseases,Viral Infections,Virus Infections,Disease, Viral,Disease, Virus,Diseases, Viral,Diseases, Virus,Infection, Viral,Infection, Virus,Infections, Viral,Infections, Virus,Viral Disease,Viral Infection,Virus Disease,Virus Infection
D016031 Liver Transplantation The transference of a part of or an entire liver from one human or animal to another. Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver

Related Publications

M Alessiani, and S Kusne, and M Martin, and A Jain, and K Abu-Elmagd, and J Moser, and S Todo, and J Fung, and T Starzl
Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression.
February 1990, Transplantation proceedings,
M Alessiani, and S Kusne, and M Martin, and A Jain, and K Abu-Elmagd, and J Moser, and S Todo, and J Fung, and T Starzl
Optimal FK 506 dosage in patients under primary immunosuppression following liver transplantation.
January 1994, Transplant international : official journal of the European Society for Organ Transplantation,
M Alessiani, and S Kusne, and M Martin, and A Jain, and K Abu-Elmagd, and J Moser, and S Todo, and J Fung, and T Starzl
Kidney transplantation under FK 506 immunosuppression.
February 1991, Transplantation proceedings,
M Alessiani, and S Kusne, and M Martin, and A Jain, and K Abu-Elmagd, and J Moser, and S Todo, and J Fung, and T Starzl
Pediatric renal transplantation under FK 506 immunosuppression.
December 1991, Transplantation proceedings,
M Alessiani, and S Kusne, and M Martin, and A Jain, and K Abu-Elmagd, and J Moser, and S Todo, and J Fung, and T Starzl
Pediatric renal transplantation under FK-506 immunosuppression.
June 1992, The Journal of urology,
M Alessiani, and S Kusne, and M Martin, and A Jain, and K Abu-Elmagd, and J Moser, and S Todo, and J Fung, and T Starzl
Intestinal transplantation in children under FK 506 immunosuppression.
August 1993, Journal of pediatric surgery,
M Alessiani, and S Kusne, and M Martin, and A Jain, and K Abu-Elmagd, and J Moser, and S Todo, and J Fung, and T Starzl
Posttransplantation lymphoproliferative disorder in patients under primary tacrolimus (FK 506) immunosuppression.
September 1995, Archives of otolaryngology--head & neck surgery,
M Alessiani, and S Kusne, and M Martin, and A Jain, and K Abu-Elmagd, and J Moser, and S Todo, and J Fung, and T Starzl
Liver transplantation of American veterans under FK 506 immunosuppression: a preliminary report.
December 1991, Transplantation proceedings,
M Alessiani, and S Kusne, and M Martin, and A Jain, and K Abu-Elmagd, and J Moser, and S Todo, and J Fung, and T Starzl
Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine.
February 1993, Transplantation proceedings,
M Alessiani, and S Kusne, and M Martin, and A Jain, and K Abu-Elmagd, and J Moser, and S Todo, and J Fung, and T Starzl
Acute hemolytic anemia in liver and bone marrow transplant patients under FK 506 therapy.
December 1991, Transplantation proceedings,
Copied contents to your clipboard!